Korea Health Industry Development Institute Discusses International Health Crisis Response at the 'World Bio Summit'

[Image source=World Bio Summit]

[Asia Economy Reporter Byeon Seon-jin] The Korea Health Industry Development Institute announced on the 26th that it will hold side events including a global roundtable conducted offline and a pre-produced WBS special session at the ‘2022 World Bio Summit,’ jointly hosted by the World Health Organization (WHO) and the Ministry of Health and Welfare.

At the global roundtable, under the theme of ‘Collaboration and Growth of Vaccine, Therapeutics, and Raw Material Companies for International Health Crisis Response,’ domestic and international companies will share their experiences in responding to COVID-19 and discuss win-win and cooperation measures for the next pandemic response. Eleven company representatives related to COVID-19 vaccines will present on strategies for the next pandemic response and desired partnership areas. Kim Young-ok, Director of Planning at the institute, will chair the discussion on ‘Future Pandemic Response Strategies from the Industry Perspective.’

The WBS special session will be a pre-produced broadcast program in collaboration with Arirang International Broadcasting, sharing expert insights on ‘Future Pandemic Prevention, Response, and Preparedness’ with the public. Various stakeholders from government, international organizations, industry, and academia will revisit efforts to overcome COVID-19 in their respective fields and share and discuss the future of the vaccine and biohealth market and technologies.

The program consists of two special lectures and a panel discussion with a total of six experts. The first special lecture features Jerome Kim, Director-General of the International Vaccine Institute, who discusses innovation and funding as key factors enabling rapid vaccine development and mass production. The second special lecture is by Paul Burton, Chief Medical Officer of Moderna, explaining that the driving force behind the rapid design, development, and supply of vaccines is messenger ribonucleic acid (mRNA).

The panel discussion includes Jeong Ki-seok, Chair of the National Infectious Disease Crisis Response Advisory Committee; Kwon Soon-man, Professor at Seoul National University Graduate School of Public Health; Kim Han, CEO of the Light Fund; Sharon Lewin, Director of the Peter Doherty Institute; Beno?t Opsumare, Vice President of Merck Life Science; and Fumie Griego, Deputy Secretary-General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). They will discuss infectious disease response measures, the role of international organizations, and vaccine accessibility. The pre-recorded program will be screened continuously throughout the event on LED billboards installed at the venue.

This content was produced with the assistance of AI translation services.